Browse All

Current Filters

CLEAR FILTER x

TITLE

The Integrated Stress Response Is Modulated by eIF2B Agonist DNL343: Results From Phase 1 Healthy Subject and Phase 1b ALS Patient Studies.

Author:Sun, Linus   Tsai, Richard   Yulyaningsih, Ernie   Fanok, Melania   Vissers, Maurits   Heuberger, Jules   Flores, Brittany   Huang, Fen   Kane, Lesley   Cohen, Isaac   Dhuria, Shyeilla   Fang, Meng   Estrada, Anthony   Osipov, Maksim   Willman-Yoswa, Brent   Maciuca, Romeo   Dobbins, Sarah   Chau, Ronnie   Earr, Timothy   Nguyen, Hoang   Lopez, Isabel   Scearce-Levie, Kimberly   Bunte, Tommy   Van den Berg, Leonard   Ho, Carole   Groeneveld, Geert-Jan   Troyer, Matthew   

Session Name:P8: Neuromuscular Disease: Amyotrophic Lateral Sclerosis 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P8.010  

Author Institution:Denali Therapeutics, South San Francisco, CA  Denali Therapeutics, San Francisco, CA  Centre for Human Drug Research/Leiden University Medical Center, Leiden, Netherlands  Denali Therapeutics, South Sa, CA  Denali Therapeutics, South San Francisco, NY  University Medical Centre Utrecht, Utrecht, Netherlands  

Association of Alzheimer’s Plasma Biomarker Concentrations with Body Mass Index in Older Adults

Author:Hoost, Serena   Brickman, Adam   Lee, Annie   Gu, Yian   Sanchez, Danurys   Reyes-Dumeyer, Dolly   Honig, Lawrence   Manly, Jennifer   Lantigua, Rafael   Kang, Min Suk   Dage, Jeffrey   Mayeux, Richard   

Session Name:P10: Aging and Dementia: Fluid Biomarkers  

Topic:Aging and Dementia  

Program Number:P10.005  

Author Institution:Vagelos College of Physicians and Surgeons, Columbia University, and the New York Presbyterian Hospital, New York, NY  Indiana University School of Medicine, Indianapolis, IN  

Benefit-Risk Assessment of Atogepant: A Post Hoc Analysis of the ADVANCE Trial

Author:Nahas, Stephanie   Ailani, Jessica   McAllister, Peter   Halker Singh, Rashmi   Lipton, Richard B.   Ma, Julia   Gandhi, Pranav   Smith, Jonathan H.   Liu, Yingyi   Chalermpalanupap, Natty   Dabruzzo, Brett   

Session Name:P12: Headache: Clinical Trials and Real World Studies 2  

Topic:Headache  

Program Number:P12.001  

Author Institution:Thomas Jefferson University, Philadelphia, PA  Medstar Georgetown Neurology, McLean, VA  New England Inst for Neurology and Headache, Stamford, CT  Mayo Clinic, Scottsdale, AZ  Albert Einstein College of Medicine, Bronx, NY  AbbVie, Madison, NJ  AbbVie, North Chicago, IL  AbbVie , Frederick, MD  

The MS-LINK Outcomes Study Cohort: Study design and a descriptive analysis of baseline key PROs, disease, and sociodemographic characteristics

Author:English, Jeffrey   Tornatore, Carlo   Riser, Emily   Pardo, Gabriel   Freeman, Leorah   Sloane, Jacob   Piette, Elizabeth   Caon, Christina   Livingston, Terrie   

Session Name:P13: MS Clinical Assessments and Outcome Measures  

Topic:MS and Inflammatory Disease  

Program Number:P13.010  

Author Institution:Multiple Sclerosis Center of Atlanta, Atlanta, GA  MedStar Georgetown University Hospital, Washington, DC  Alabama Neurology Associates, Birmingham, AL  Oklahoma Medical Research Foundation, Oklahoma City, OK  Dell Medical School, The University of Texas at Austin, Austin, TX  Beth Israel Deaconess Medical Center, Boston, MA  EMD Serono, Inc., Rockland, MA  

Feasibility of Measuring Functional Performance of FSHD Patients Using Wearable Sensors to Quantify Physical Activity

Author:Kools, Joost   Voermans, Nicol   Mul, Karlien   Jiang, John   Shoskes, Jennifer   Marshall, Kelly   Tarachandani, Anil   Figueredo, Joanita   Eggenspieler, Damien   

Session Name:S7: Outcome Measures and Observational Studies of Neuromuscular Diseases  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S7.006  

Author Institution:Radboudumc, Nijmegen, Netherlands  Fulcrum Therapeutics, Cambridge, MA  UsinLife, LLC, Whitehouse Station, NJ  Sysnav SAS, Vernon, France